Actively Recruiting
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Led by Sherief Abd-Elsalam · Updated on 2019-04-29
120
Participants Needed
1
Research Sites
504 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.
CONDITIONS
Official Title
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM)
You will not qualify if you...
- Presence of viral hepatitis
- Child-Pugh score greater than 6
- Renal impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, Egypt, 35111
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here